These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7979730)

  • 1. Study of efficacies of leukocyte-depleted terminal blood cardioplegia in 24-hour preserved hearts.
    Fukushima N; Shirakura R; Nakata S; Kaneko M; Miyagawa S; Naka Y; Chang JC; Matsumiya G; Nakano S; Matsuda H
    Ann Thorac Surg; 1994 Dec; 58(6):1651-6. PubMed ID: 7979730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 hours.
    Fukushima N; Shirakura R; Nakata S; Kaneko M; Sawa Y; Matsuwaka R; Naka Y; Matsumiya G; Matsuda H
    J Heart Lung Transplant; 1992; 11(4 Pt 1):676-82. PubMed ID: 1498130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collins' solution for cold storage of the heart for transplantation must be reversed with cardioplegic solution before reperfusion. A functional and metabolic study in the rat heart.
    Toshima Y; Kohno H; Matsuzaki K; Mitani A; Mayumi H; Yasui H; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1572-81. PubMed ID: 1453722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy state of the myocardium during long-term cold storage and subsequent reperfusion.
    Flameng W; Dyszkiewicz W; Minten J
    Eur J Cardiothorac Surg; 1988; 2(4):244-55. PubMed ID: 3272228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved heart preservation with UW preservation solution.
    Swanson DK; Pasaoglu I; Berkoff HA; Southard JA; Hegge JO
    J Heart Transplant; 1988; 7(6):456-67. PubMed ID: 3145337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes.
    Hayashi Y; Sawa Y; Fukuyama N; Miyamoto Y; Takahashi T; Nakazawa H; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1813-21. PubMed ID: 14688692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful transplantation after long-term preservation of dog hearts.
    Möllhoff T; Sukehiro S; Van Belle H; Van Aken H; Flameng W
    Anesthesiology; 1992 Aug; 77(2):291-300. PubMed ID: 1642349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation. A study of left ventricular pressure-volume relationship.
    Ko W; Zelano JA; Lazzaro R; Lazenby WD; Hamilton T; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1992 May; 103(5):980-92. PubMed ID: 1569779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of remote perconditioning with terminal blood cardioplegia in an in vivo piglet model.
    Abe T; Morita K; Shinohara G; Hashimoto K; Nishikawa M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):479-484. PubMed ID: 28874030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amino acids and enhancement cardioplegia in routine myocardial protection. Experimental results.
    Crooke GA; Harris LJ; Grossi EA; Baumann FG; Esposito R; Spencer FC; Colvin SB; Galloway AC
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):497-501. PubMed ID: 8361193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial energy metabolism in asphyxiated canine hearts preserved for 24 hours.
    Shirakura R; Matsuda H; Nakano S; Nakata S; Kaneko M; Takami H; Miyagawa S; Fukushima N; Kitagawa S; Naka Y
    Transplantation; 1992 Jun; 53(6):1215-8. PubMed ID: 1604476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pressure on myocardial function after 6-hour preservation with blood cardioplegia.
    Li G; Sullivan JA; You JM; Hall RI
    Ann Thorac Surg; 1998 Jan; 65(1):115-24. PubMed ID: 9456105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of terminal cardioplegia with leukocyte-depleted blood on myocardial adenosine triphosphate in heart grafts preserved for 24 hours.
    Fukushima N; Shirakura R; Nakata S; Kaneko M; Miyagawa S; Kitagawa S; Chang J; Amemiya A; Matsumiya G; Matsuda H
    Transplant Proc; 1992 Aug; 24(4):1489-90. PubMed ID: 1496630
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term preservation of donor hearts: the effect of intra- and extracellular-type of cardioplegic solutions on myocardial high energy phosphate content.
    Dyszkiewicz W; Minten J; Flameng W
    Mater Med Pol; 1990; 22(3):147-52. PubMed ID: 2132419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collins blood diluting reperfusion--an effective measure of controlled reperfusion for the heart hypothermically preserved for 24 hours in modified Collins solution].
    Yokoyama H; Okamoto F; Kikuchi S; Inoue N; Kazui T; Abe T; Komatsu S
    Nihon Kyobu Geka Gakkai Zasshi; 1991 Jul; 39(7):996-1004. PubMed ID: 1895003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete functional recovery after 24-hour heart preservation with University of Wisconsin solution and modified reperfusion.
    Stein DG; Permut LC; Drinkwater DC; Bhuta S; Chang P; Wu A; Laks H
    Circulation; 1991 Nov; 84(5 Suppl):III316-23. PubMed ID: 1682070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial.
    Pearl JM; Drinkwater DC; Laks H; Capouya ER; Gates RN
    J Heart Lung Transplant; 1992; 11(6):1082-92. PubMed ID: 1457432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart preservation: analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a biochemical, ultrastructural, functional study.
    Sultan I; Sunamori M; Suzuki A
    J Heart Lung Transplant; 1992; 11(4 Pt 1):607-18. PubMed ID: 1379828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioplegia for heart transplantation: unmodified UW solution compared with Stanford solution.
    Gott JP; Brown WM; Pan-Chih ; Dorsey LM; Walker B; Guyton RA
    J Heart Lung Transplant; 1992; 11(2 Pt 1):353-61; discussion 362. PubMed ID: 1576141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.